The Coalition for Epidemic Preparedness Innovations will expand its COVID-19 vaccine testing network -- a global group of labs testing vaccine candidates using the same methods and materials -- to include development of vaccines against other epidemic and pandemic diseases, including diseases such as Chikungunya, Lassa fever, Middle East respiratory syndrome, Nipah, Rift Valley fever and a so-called ‘Disease X,’ the organization announced Monday (Nov. 22). CEPI has already begun supporting the development of multiple vaccines against high-risk pathogens as...